International

Aragen Life Sciences begins operations at a high-potency development manufacturing platform in Hyderabad

The Hindu
By The Hindu Staff
11 hours ago 5 views
Aragen Life Sciences begins operations at a high-potency development manufacturing platform in Hyderabad
Photo credit: The Hindu
Advertisement

IPO-bound contract research, development and manufacturing organisation (CRDMO) Aragen Life Sciences has begun operations at Aragen OneHP, a high-potency development and manufacturing platform at its Nacharam campus in Hyderabad.

Aragen OneHP spans around 15,000 sq ft and operates one manufacturing line with a designed capacity of 500-600 kg of active pharmaceutical ingredient per year. It can support highly potent compounds, including cytotoxic molecules and targeted oncology therapies. The facility will also lay the foundation for future expansion into advanced modalities such as antibody-drug conjugates and peptide-drug conjugates, the company said on Wednesday (October 7, 2026).

Advertisement
Originally published by The Hindu on Oct 7, 2026 Read the full article at thehindu.com
Read original
About this page. Sisnoo is an aggregator. This article was imported from a publisher feed and may have been reformatted. Copyright remains with the original publisher, and the headline, image and any quoted text are used for attribution and indexing purposes. Source links are preserved on every item in the archive.
Share

Comments

0 comments
Comments are plain text. Links may hold your comment for moderation.

No comments yet — be the first.

Advertisement

More from The Hindu

View source

Related

Categories

  1. Everything
  2. International
  3. Politics
  4. Nepal
  5. Finance
  6. Sports
  7. Entertainment
  8. Lifestyle
  9. Technology
  10. Literature
  11. Science
  12. Health